Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700984 · ClinicalTrials.gov registry record · NA
A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 282
- Enrollment target
NCT02700984 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 282 participants.
The verdict
NCT02700984, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.
Interventions
- PROCEDURE Cataract Surgery
- DEVICE CyPass Micro-Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2016-03-30 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02700984
The ClinicalTrials.gov registry entry for NCT02700984 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cataract Surgery is the first listed.
NCT02700984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02700984 about?
NCT02700984 is a clinical study titled "A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial". The purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.
What is the current status of trial NCT02700984?
This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2016-03-30. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT02700984?
The interventions under investigation include: Cataract Surgery (PROCEDURE), CyPass Micro-Stent (DEVICE).
Who is sponsoring clinical trial NCT02700984?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.